ClinicalTrials.gg
RecruitingNCT04849130DynMPFLUpdated Apr 22, 2025

Comparison of Dynamic and Static Medial Patellofemoral Ligament Operation Technique for Recurrent Patellar Dislocation

An interventional study of Static reconstruction technique according to Schöttle and Dynamic reconstruction technique according to Becher in Patellar Instability, sponsored by University Hospital, Basel, Switzerland. Recruiting at 2 sites in Switzerland. Open to participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2025-04-22.

Sponsored by University Hospital, Basel, Switzerland · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2021; still recruiting 5 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
14 Years and older
Sex
All
01

Study summary

This study is to evaluate whether the dynamic Medial Patellofemoral Ligament (MPFL) reconstruction as described by Becher is a successful operation technique to prevent patella instability and restore quality of life. It is to assess and compare clinical and functional outcomes of dynamic and static medial patellofemoral ligament reconstruction

Read the detailed description

The recurrent dislocation rate of conservatively treated chronic patellar instability is high, therefore, it is recommended to manage it surgically. A frequently used surgical technique is static medial patellofemoral ligament (MPFL) reconstruction (e.g. Schöttle-technique). A novel dynamic surgical technique according to Becher was developed, addressing the most common complications occurring in static reconstruction, which are malpositioning and overtensioning of the graft. This study is to assess and compare clinical and functional outcomes of dynamic and static medial patellofemoral ligament reconstruction.

02

Conditions studied

  • Patellar Instability

Browse trials for

Keywords

  • chronic patellar instability
  • static medial patellofemoral ligament (MPFL) reconstruction
  • static reconstruction technique according to Schöttle
  • dynamic medial patellofemoral ligament (MPFL) reconstruction
  • patellofemoral ligament reconstruction
  • patella dislocation
  • Patella-Instability-Severity (PIS) score
  • dynamic reconstruction technique according to Becher
03

In context

Patellar Dislocation

41 studies on the registry are indexed under Patellar Dislocation; 9 are open to participants now.

This study's planned enrollment of 60 is above the median of 50 across 22 interventional studies indexed under Patellar Dislocation.

Browse Patellar Dislocation studies →

Lead sponsor

University Hospital, Basel, Switzerland is the lead sponsor of 990 studies on the registry; 189 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients treated with isolated dynamic (operation procedure according to Becher et al.using the gracilis tendon) or static MPFL plastic (operation procedure according to Schöttle et al. using the gracilis tendon). MPFL reconstruction will be performed in patients with preceding patella dislocation with: 1) a Patella-Instability-Severity (PIS) score ≤ 3 with concomitant flake fracture or 2) a PIS score ≥ 4 with clinical asymptomatic trochlea dysplasia (patella stability between 30°-60° knee flexion) without other static risk factors.
  • Closed growth plates

Exclusion criteria

Exclusion Criteria:

  • Combined procedures with trochleoplasty (high grade trochlea dysplasia, type Dejour C,D with clinical instability between 30° and 60° of knee flexion)
  • combined procedures with cartilage transplantation
  • High grade patellofemoral arthritis (Kellgren Lawrence score ≥3)
  • combined procedures with femoral or tibial osteotomy
  • Clinically eminent valgus axis (>15° valgus)
  • Femoral internal rotation >20°, tibial external rotation >40°
  • Instability of the cruciate or collateral ligaments
  • Known significant musculoskeletal disease
  • Cognitive impairment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Static reconstruction technique according to Schöttle

    Static reconstruction technique according to Schöttle

    Procedure: Static reconstruction technique according to Schöttle

  • Active comparator
    Dynamic reconstruction technique according to Becher

    Dynamic reconstruction technique according to Becher

    Procedure: Dynamic reconstruction technique according to Becher

Interventions

  • ProcedureStatic reconstruction technique according to Schöttle

    In static MPFL reconstruction, a graft (harvested autologous gracilis tendon or allogen transplant) is attached to the femoral and patellar bones using tunnels, screws, and/or anchors.

  • ProcedureDynamic reconstruction technique according to Becher

    Dynamic MPFL procedure by detaching and reinserting only the distal part of a hamstring muscle to the patella and leaving the proximal tendon attached to its muscle. This way the patella position can be adjusted dynamically by hamstring contraction.

06

What researchers measure

Primary outcomes

  1. Change in Kujala score

    Patient reported knee function and anterior knee pain as assessed with the Kujala score at preoperative screening, at the hospitalization time and four postoperative follow ups . The Kujala scale consists of 13 questions covering a range of physical symptoms and limitations that are presented in a multiple choice answer format, with a different point value assigned to each answer. The maximum score is 100, with higher scores indicating better function.

    Time frame: up to 24 months

Secondary outcomes

  1. Number of recurrent patella dislocation

    Surgical outcome: recurrent patella dislocation.

    Time frame: From MPFL surgery to occurring recurrent patella dislocation (up to 24 months)

  2. Number of revision surgery

    Surgical outcome: revision surgery.

    Time frame: From MPFL surgery to occurring revision surgery (up to 24 months)

  3. Number of complications (other than revision surgery, e.g. infection, wound healing disorder)

    Surgical outcome: complications (other than revision surgery, e.g. infection, wound healing disorder).

    Time frame: From MPFL surgery to occurring complication (up to 24 months)

  4. Change in Banff-II-score from preoperative screening, at the hospitalization time and four postoperative follow ups

    The Banff Patella Instability Instrument (BPII) is a disease-specific health-related quality of life score. It is a patient-reported, disease-specific QOL score that consists of 23 questions across five domains covering symptoms/physical complains, work-related concerns, recreational activity and sport participation/competition, lifestyle, and social/emotional. Patients mark their answers on a visual analogue scale measuring 100 mm in length. Each item is equally weighted with the final score calculated as an average of the scores from all answered items. A higher score reflects a higher QOL.

    Time frame: up to 24 months

  5. Change in International Knee Documentation Committee (IKDC)-2000 from preoperative screening, at the hospitalization time and four postoperative follow ups

    The IKDC includes 18 questions covering three domains: symptoms, physical activity, and function. The items are answered on Likert scales of varying values. IKDC scores are calculated by dividing the total score by the highest possible score for the items answered, and multiplying by 100, with higher scores indicating better function.

    Time frame: up to 24 months

  6. Change in EQ-5D-5L from preoperative screening, at the hospitalization time and four postoperative follow ups EQ-5D- EQ-5D-5L

    The EQ-5D descriptive system comprises five dimensions: mobility, self-care, usual activities, pain and discomfort, and anxiety and depression. The five levels in each dimension are worded as (1) 'not /no problems', (2) 'slight problems', (3) 'moderate problems', (4) 'severe problems', and (5) 'unable to' (mobility, self-care, usual activities), 'extreme' (pain/depression), or 'extremely' (anxiety/depression).

    Time frame: up to 24 months

  7. Change in pain level using the numeric rating scale from preoperative screening, at the hospitalization time and four postoperative follow ups

    It is usually presented as a 100-mm horizontal line on which the patient's pain intensity is represented by a point between the extremes of "no pain at all" and "worst pain imaginable."

    Time frame: up to 24 months

  8. Operation time

    Operation time

    Time frame: During MPFL surgery (up to 1 day)

  9. Hospitalization time

    Length of hospital stay Length of hospital stay

    Time frame: During hospitalization (up to 1 month)

  10. Change in gait asymmetry

    Instrumented gait analysis (by EMG) on a treadmill with an embedded plantar pressure plate and on an overground walkway with two embedded force plates.

    Time frame: Preoperatively and 1 year postoperative

  11. Change in isokinetic muscle strength

    Muscle strength will be measured bilaterally using a dynamometer.

    Time frame: Preoperatively and 1 year postoperative

  12. Change in timing of muscle activity

    Timing of the gracilis muscle will be assessed as on- and offset relative to the gait cycle. Gracilis onset will be determined as the time when the processed EMG signal exceeded a threshold of three standard deviations above a baseline mean and as offset, when the processed EMG signal falls below a threshold of three standard deviations above a baseline mean.

    Time frame: Preoperatively and 1 year postoperative

  13. Change in single legged drop test

    Standing erect upon only the tested leg with the foot in neutral position, participants will step off a 30 cm high platform placed 11 cm from the edge of the force-plate. Participants will be instructed to land in the centre of the force-plate on the tested leg only.

    Time frame: Preoperatively and 1 year postoperative

07

Study locations

2 of 2 sites recruiting
  • Department of Orthopaedics and Traumatology, University Hospital Basel
    Basel, 4031, Switzerland
    Recruiting
  • Department of Orthopaedics and Traumatology, Swiss Altius Medical Clinic
    Rheinfelden, 4310, Switzerland
    Recruiting
08

References and documents

Publications

  • Bartsch A, Nuesch C, Rieger B, Mundermann A, Egloff C. Dynamic versus static medial patellofemoral ligament reconstruction technique in the treatment of recurrent patellar dislocation: a randomized clinical trial protocol. J Orthop Surg Res. 2022 Jul 10;17(1):345. doi: 10.1186/s13018-022-03158-6. PubMed 35818060 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04849130
Responsible party
Sponsor
First posted
Apr 19, 2021
Start date
May 10, 2021
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Apr 22, 2025

Study contacts

Christian Egloff, PD Dr. med.
Contact
christian.egloff@usb.ch
+41 79 75 33 72 4
Daniel Rikli, Prof. Dr. med.
Contact
daniel.rikli@usb.ch
+41 79 75 33 72 4
Christian Egloff, PD Dr. med.
principal investigator · Department of Orthopaedics and Traumatology, University Hospital Basel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion